- Home
- HONE vs TYRA Comparison
HONE vs TYRA Comparison
Compare HONE & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- TYRA
- Stock Information
- Founded
- HONE 1917
- TYRA 2018
- Country
- HONE United States
- TYRA United States
- Employees
- HONE N/A
- TYRA N/A
- Industry
- HONE Major Banks
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- TYRA Health Care
- Exchange
- HONE Nasdaq
- TYRA Nasdaq
- Market Cap
- HONE 513.0M
- TYRA 580.2M
- IPO Year
- HONE 2016
- TYRA 2021
- Fundamental
- Price
- HONE $11.61
- TYRA $10.37
- Analyst Decision
- HONE Buy
- TYRA Strong Buy
- Analyst Count
- HONE 3
- TYRA 7
- Target Price
- HONE $14.50
- TYRA $30.86
- AVG Volume (30 Days)
- HONE 258.2K
- TYRA 241.1K
- Earning Date
- HONE 07-24-2025
- TYRA 08-11-2025
- Dividend Yield
- HONE 3.10%
- TYRA N/A
- EPS Growth
- HONE 71.76
- TYRA N/A
- EPS
- HONE 0.65
- TYRA N/A
- Revenue
- HONE $164,819,000.00
- TYRA N/A
- Revenue This Year
- HONE N/A
- TYRA N/A
- Revenue Next Year
- HONE $9.44
- TYRA N/A
- P/E Ratio
- HONE $17.88
- TYRA N/A
- Revenue Growth
- HONE N/A
- TYRA N/A
- 52 Week Low
- HONE $8.89
- TYRA $6.42
- 52 Week High
- HONE $13.73
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- HONE 40.86
- TYRA 48.30
- Support Level
- HONE $11.97
- TYRA $10.71
- Resistance Level
- HONE $12.32
- TYRA $11.66
- Average True Range (ATR)
- HONE 0.25
- TYRA 0.63
- MACD
- HONE -0.08
- TYRA -0.01
- Stochastic Oscillator
- HONE 10.00
- TYRA 18.25
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.